- Investing Ideas
- /
- U.K. Pharmaceuticals & Biotech High Growth Potential Companies
U.K. Pharmaceuticals & Biotech High Growth Potential Companies
Results
12
0 new
Companies with a Future performance score of at least 3, ordered by Future performance score.
12 companies
| Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | ||
|---|---|---|---|---|---|---|---|---|---|---|
OXB | UK£4.13 | -1.7% | 131.5% | UK£448.1m | UK£5.33 | PS4.5x | E92.5% | n/a | ||
HCM | UK£2.25 | 2.3% | 11.4% | UK£1.9b | UK£4.40 | PS3.9x | E38.5% | n/a | ||
FUM | UK£0.17 | -46.9% | -43.1% | UK£94.1m | UK£1.34 | PS6x | E188.6% | n/a | ||
LLAI | UK£0.10 | -8.9% | -75.9% | UK£3.0m | UK£1.71 | PS134.9x | E101.0% | n/a | ||
AZN | UK£113.14 | 2.4% | 8.5% | UK£174.2b | UK£138.93 | PE33.6x | E16.9% | 2.0% | ||
GSK | UK£14.02 | 2.8% | -11.6% | UK£57.1b | UK£17.94 | PE22.8x | E20.8% | 4.1% | ||
APH | UK£0.61 | 0.2% | 64.3% | UK£330.3m | UK£0.63 | PS1.8x | E66.3% | 0% | ||
EAH | UK£0.64 | -0.8% | -41.0% | UK£43.7m | UK£1.60 | PE65.9x | E39.2% | 0% | ||
INDV | UK£9.80 | 2.1% | -27.5% | UK£1.2b | UK£13.12 | PS1.3x | E42.6% | 0% | ||
TRX | UK£0.58 | -1.7% | -7.9% | UK£42.0m | UK£1.20 | PS1.6x | E170.8% | n/a | ||
GNS | UK£18.94 | 10.0% | -14.8% | UK£1.2b | UK£24.64 | PE157.5x | E37.2% | 1.7% | ||
DXRX | UK£1.37 | -6.2% | 31.7% | UK£117.1m | UK£1.93 | PS4.4x | E86.5% | n/a |
Page 1 of 1